Ignite Creation Date:
2025-12-25 @ 4:40 AM
Ignite Modification Date:
2026-01-22 @ 12:49 PM
Study NCT ID:
NCT04055818
Status:
RECRUITING
Last Update Posted:
2025-05-25
First Post:
2019-08-12
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Nicotinamide With Oral Tetrahydrouridine and Decitabine to Treat High Risk Sickle Cell Disease
Sponsor:
EpiDestiny, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
2019-0631
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None